Nephro Health, a prominent provider of dialysis and kidney care services, launched its IPO on December 11, 2025. The offering has attracted investor interest as the company aims to expand its network of clinics and dialysis services nationwide. Here’s a comprehensive look at the Nephro Health IPO, including subscription status and key financial details.
Market Response and Subscription Status
The IPO opened for bidding on Wednesday, December 11, and is scheduled to close on Friday, December 12, 2025.
On the second day of subscription, the IPO witnessed the following subscriptions across investor categories:
- Employee Quota: 0.78 times
- Retail Investors: 0.32 times
- Non-Institutional Investors (NIIs): 0.13 times
- Qualified Institutional Buyers (QIBs): 0.30 times
The IPO is structured to attract investors across categories while ensuring broad participation.
Nephro Health IPO Details
- Total IPO Size: ₹871.05 crore
- Fresh Issue: ₹353.40 crore (0.77 crore shares)
- Offer for Sale (OFS): ₹517.64 crore (1.13 crore shares)
- Price Band: ₹438 to ₹460 per share
- Lot Size: 32 shares
- Minimum Retail Investment: ₹14,720
- Category Allocation:
- QIB: 75%
- NII: 15%
- Retail Investors: 10%
- Tentative Listing Date: Wednesday, December 17, 2025, on BSE and NSE
IPO Allotment Timeline
- Allotment Finalisation: Monday, December 15, 2025
- Refunds Processed: Tuesday, December 16, 2025
- Shares Credited to Demat Accounts: Same day as refunds
About Nephro Health
Nephrocare Health Services provides comprehensive dialysis care through its network of clinics across India. The company offers:
- Hemodialysis
- Home and mobile dialysis
- Pharmacy services
- Wellness programs
In FY25, Nephro Health treated 29,281 patients and delivered 2,885,450 dialysis sessions, accounting for 10% of India’s total dialysis patient population.
The company’s services cover diagnosis, treatment, and follow-up care, positioning it as a trusted player in kidney care and dialysis solutions.
Use of IPO Proceeds
The funds raised through the Nephro Health IPO will be utilised to:
- Establish new dialysis clinics across India
- Repay existing debt
- Support general corporate purposes
This allocation ensures continued growth while strengthening the company’s operational and financial position.
Summary
The Nephro Health IPO 2025 offers investors a chance to be part of India’s expanding dialysis and kidney care industry. Allotments are expected on December 15, 2025, with shares tentatively set to list on December 17, 2025, providing access to a well-established healthcare provider with a large patient network and an expanding presence across the country.
Easy & quick
Leave A Comment?